Xin Jiang

发表

Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies.

R. Simon, W. Levin, A. Erbersdobler, 2011, Cancer research.

BET inhibitor I-BET151 sensitizes GBM cells to temozolomide via PUMA induction

Hongyou Zhao, Zhicheng Yao, Huike Yang, 2019, Cancer Gene Therapy.

Anti-CD69 monoclonal antibody treatment inhibits airway inflammation in a mouse model of asthma

Hui‐ying Wang, Xuyan Yang, Xin Jiang, 2015, Journal of Zhejiang University-SCIENCE B.

Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer

Xiaokun Li, J. Ji, G. Liang, 2015, BMC Cancer.

FGFR3 Destabilizes PD-L1 via NEDD4 to Control T-cell–Mediated Bladder Cancer Immune Surveillance

Shouzhen Chen, B. Shi, Yue Li, 2021, Cancer Research.

Hsp90 inhibitor sensitizes TRAIL-mediated apoptosis via chop-dependent DR5 upregulation in colon cancer cells.

Zhiyong Zhu, Ang Chen, Xin Li, 2017, American journal of translational research.

Dual functional monoclonal antibody PF-04605412 targets integrin alpha5beta1 and elicits potent antibody-dependent cellular cytotoxicity.

S. Bender, Lianglin Zhang, S. Bergqvist, 2010, Cancer research.

Hsp 90 inhibitor sensitizes TRAIL-mediated apoptosis via chop-dependent DR 5 upregulation in colon cancer cells

Zhiyong Zhu, Ang Chen, Xin Li, 2017 .

Berberine reduces temozolomide resistance by inducing autophagy via the ERK1/2 signaling pathway in glioblastoma

Xin Gao, L. Na, Zhicheng Yao, 2020, Cancer Cell International.

Anti-CD69 monoclonal antibody treatment inhibits airway inflammation in a mouse model of asthma

Hui‐ying Wang, Xuyan Yang, Xin Jiang, 2015, Journal of Zhejiang University-SCIENCE B.